{
  "title": "PREVENT ALL ALS Dataset",
  "source": "ALL ALS",
  "disease": [
    "ALS"
  ],
  "species": [
    "Homo sapiens"
  ],
  "dataType": [
    "clinical_assessment",
    "medical_history",
    "laboratory_results",
    "vital_signs",
    "neurological_assessment",
    "electrophysiology",
    "hand_held_dynamometry",
    "genetic_profile",
    "study_management"
  ],
  "keywords": [
    "ALS prevention study",
    "neurological exam",
    "motor/cognitive screening",
    "muscle & grip strength",
    "handheld dynamometry",
    "vital capacity",
    "EMG/NCS",
    "ECAS",
    "MIR",
    "ALS gene variants (C9ORF72,SOD1,FUS,TARDBP)",
    "blood/serum/plasma",
    "CSF via LP",
    "longitudinal cohort"
  ],
  "studyType": [
    "Clinical Trial"
  ],
  "contributor": [
    "Access for All in ALS (ALL ALS)"
  ],
  "portalRelease": [
    "2026.1"
  ],
  "diseaseSubtype": [
    "C9-ALS",
    "SOD1-ALS",
    "ANG-ALS",
    "ANXA11-ALS",
    "ARHGEF28-ALS",
    "ATXN2-ALS",
    "CFAP410-ALS",
    "CHCHD10-ALS",
    "CHMP2B-ALS",
    "DAO-ALS",
    "DCTN1-ALS",
    "ERBB4-ALS",
    "FIG4-ALS",
    "FUS-ALS",
    "HNRNPA1-ALS",
    "HNRNPA2B1-ALS",
    "KIF5A-ALS",
    "MATR3-ALS",
    "MOBP-ALS",
    "NEFH-ALS",
    "NEK1-ALS",
    "OPTN-ALS",
    "PFN1-ALS",
    "SETX-ALS",
    "SQSTM1-ALS",
    "TAF15-ALS",
    "TARDBP-ALS",
    "TBK1-ALS",
    "TUBA4A-ALS",
    "UBQLN2-ALS",
    "UNC13A-ALS",
    "VAPB-ALS",
    "VCP-ALS",
    "ALS2-ALS",
    "ELP3-ALS",
    "EPHA4-ALS",
    "EWSR1-ALS",
    "KIKAP3-ALS",
    "PRPH-ALS",
    "SPG4-ALS",
    "SPG11-ALS",
    "Other genetic ALS"
  ],
  "participant_count": 265,
  "acknowledgementStatement": [
    "syn64892175/wiki/633965"
  ],
  "description": "Multi-site longitudinal natural history study of asymptomatic individuals at genetic risk for ALS. Collects neurological exams, ECAS, HHD, vital capacity, EMG, digital speech, blood/CSF biospecimens, genetic testing results, symptom questionnaires, and DHT wearables. Tracks phenoconversion to ALS. N=169.",
  "alternateName": "PREVENT ALL ALS",
  "creator": [
    "Access for All in ALS (ALL ALS)"
  ],
  "subject": [
    "Amyotrophic lateral sclerosis--Prevention",
    "Neurodegenerative diseases--Genetic aspects",
    "Motor neuron diseases--Research"
  ],
  "funder": [
    "National Institutes of Health"
  ],
  "collection": [
    "all_als"
  ],
  "curationLevel": "tier2",
  "includedInDataCatalog": "",
  "citation": [],
  "publisher": "Sage Bionetworks",
  "license": "",
  "url": "",
  "sameAs": "",
  "studyDesign": "longitudinal",
  "primaryOutcome": "Phenoconversion to ALS and rate of neurological decline in at-risk gene carriers",
  "assessmentTypes": [
    "neurological_exam",
    "vital_signs",
    "laboratory",
    "electrophysiology",
    "dynamometry",
    "genetic_testing"
  ],
  "visitSchedule": "Screening; Visits 1, 1a, 2\u20137; LP eligibility visits; Genetic counseling appointments; Follow-up telephone visits; DHT sub-study visits; Early Termination",
  "clinicalDomain": [
    "motor_function",
    "respiratory_function",
    "disease_progression",
    "symptom_onset",
    "genetic_testing",
    "biomarkers",
    "cognitive_assessment"
  ],
  "_dataset_type": "ClinicalDataset",
  "_schema_source": "data-model",
  "_created_timestamp": "2026-02-17T12:05:59.518564"
}
